Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-030815
Filing Date
2021-03-02
Accepted
2021-03-02 16:45:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tm218429d1_sc13da.htm SC 13D/A 30254
  Complete submission text file 0001104659-21-030815.txt   32144
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filed by) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 MUSICK IRVINE CA 92618
Business Address 5 MUSICK IRVINE CA 92618 9499006833
ClearPoint Neuro, Inc. (Subject) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86852 | Film No.: 21704511
SIC: 3841 Surgical & Medical Instruments & Apparatus